ALAB Astera Labs, Inc.
Semiconductors & Related Devices · Nasdaq · SEC CIK 1736297 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY115.2%
TTM net income YoY132.0%
TTM EPS YoY107.4%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin73.9%
Operating margin25.5%
Net margin29.6%
FCF margin22.1%
EBITDA margin26.5%
Returns
ROE28.2%
ROA24.9%
ROIC (approx.)27.2%
Asset turnover0.84x
Leverage & solvency
Liabilities / assets13.1%
Debt / equity0.00x
Current ratio8.03x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.95x
Accruals ratio1.3%
Payout ratio—
Capex / revenue5.9%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $584.90M | $392.40M | $308.36M | $270.58M | $230.57M | $191.93M | $159.44M | $141.10M |
| Cost of revenue | $162.15M | $104.83M | $73.22M | $66.11M | $54.76M | $46.36M | $40.03M | $36.65M |
| Gross profit | $422.75M | $287.57M | $235.14M | $204.47M | $175.81M | $145.56M | $119.41M | $104.45M |
| R&D expense | $170.96M | $135.90M | $125.63M | $93.79M | $78.93M | $66.72M | $64.55M | $56.52M |
| SG&A expense | $35.31M | $36.05M | $25.77M | $23.62M | $22.12M | $20.46M | $21.87M | $24.96M |
| Operating income | $179.06M | $89.25M | $61.83M | $66.96M | $55.41M | $39.77M | $11.29M | $144,000 |
| Pretax income | $192.03M | $102.83M | $73.41M | $78.92M | $66.86M | $50.66M | $21.72M | $10.70M |
| Income tax | $9.08M | -$50.26M | -$6.90M | $33.93M | -$24.25M | -$560,000 | -$10.10M | -$14.01M |
| Net income | $182.94M | $153.09M | $80.31M | $44.98M | $91.11M | $51.22M | $31.82M | $24.71M |
| EBITDA | $184.16M | $93.15M | $65.53M | $69.80M | $56.91M | $41.17M | $12.38M | $1.12M |
| EPS (basic) | 1.05 | 0.89 | 0.47 | — | 0.54 | 0.31 | 0.19 | — |
| EPS (diluted) | 0.99 | 0.83 | 0.44 | — | 0.50 | 0.29 | 0.18 | — |
| Weighted avg. shares (diluted) | 184.08M | 183.34M | 181.16M | — | 180.63M | 178.10M | 178.12M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $209.40M | $111.45M | $148.28M | $167.61M | $141.48M | $163.40M | $86.99M | $80.04M |
| Short-term investments | $1.17B | $1.14B | $1.04B | $1.02B | $994.02M | $902.76M | $838.29M | $834.75M |
| Receivables | $284.25M | $192.47M | $134.80M | $83.20M | $42.90M | $24.32M | $69.78M | $38.81M |
| Inventory | $200.89M | $113.78M | $60.16M | $58.98M | $51.66M | $58.60M | $51.06M | $43.22M |
| Current assets | $1.96B | $1.65B | $1.41B | $1.36B | $1.29B | $1.18B | $1.08B | $1.01B |
| PP&E, net | $170.71M | $119.28M | $97.17M | $92.04M | $72.48M | $62.08M | $39.47M | $35.65M |
| Goodwill | $91.56M | $91.56M | $87.72M | $19.02M | — | — | — | — |
| Total assets | $2.30B | $1.93B | $1.66B | $1.53B | $1.40B | $1.27B | $1.12B | $1.05B |
| Current liabilities | $243.58M | $164.31M | $125.04M | $133.04M | $100.96M | $106.38M | $77.28M | $86.54M |
| Total liabilities | $300.87M | $205.80M | $165.27M | $168.19M | $129.45M | $135.69M | $80.13M | $89.71M |
| Shareholders' equity | $2.00B | $1.73B | $1.49B | $1.36B | $1.27B | $1.14B | $1.04B | $964.80M |
| Shares outstanding | 174.75M | 173.49M | 171.28M | 170.19M | 168.90M | 166.21M | 164.91M | 162.02M |
| Cash flow statement | ||||||||
| Operating cash flow | $179.20M | $87.68M | $74.60M | $95.27M | $78.17M | $135.37M | $10.50M | $39.70M |
| Capital expenditure | $45.31M | $20.47M | $7.59M | $18.69M | $12.29M | $2.02M | $4.54M | $15.45M |
| Free cash flow | $133.89M | $67.21M | $67.01M | $76.58M | $65.88M | $133.34M | $5.96M | $24.25M |
| Investing cash flow | -$81.22M | -$131.56M | -$94.01M | -$72.79M | -$101.05M | -$63.69M | -$3.94M | -$91.43M |
| Financing cash flow | -$34,000 | $7.05M | $82,000 | $3.73M | $952,000 | $4.74M | $386,000 | $5.65M |
| Depreciation & amortization | $5.10M | $3.90M | $3.70M | $2.85M | $1.50M | $1.40M | $1.10M | $974,000 |
| Stock-based compensation | $82.59M | $63.99M | $48.91M | $41.37M | $40.74M | $35.47M | $42.45M | $48.22M |
Free plan shows the latest 8 periods; Pro shows all 15 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.